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Abstract: Sulfatide is a myelin glycolipid that functions in the formation of paranodal axo-
glial junctions in vivo and in the regulation of oligodendrocyte diﬀerentiation in vitro. Cerebroside
sulfotransferase (CST) catalyzes the production of two sulfated glycolipids, sulfatide and
proligodendroblast antigen, in oligodendrocyte lineage cells. Recent studies have demonstrated
signiﬁcant increases in oligodendrocytes from the myelination stage through adulthood in brain and
spinal cord under CST-deﬁcient conditions. However, whether these result from excess migration or
in situ proliferation during development is undetermined. In the present study, CST-deﬁcient optic
nerves were used to examine migration and proliferation of oligodendrocyte precursor cells (OPCs)
under sulfated glycolipid-deﬁcient conditions. In adults, more NG2-positive OPCs and fully
diﬀerentiated cells were observed. In developing optic nerves, the number of cells at the leading edge
of migration was similar in CST-deﬁcient and wild-type mice. However, BrdUD proliferating OPCs
were more abundant in CST-deﬁcient mice. These results suggest that sulfated glycolipids may be
involved in proliferation of OPCs in vivo.
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Introduction
Galactocerebroside and its sulfated analogue,
sulfatide, are two major glycolipids, constituting
30% of the total myelin lipids. The roles of these
glycolipids in oligodendrocyte development and
myelination in vivo have been examined using
mutant mice with disruptions in genes for either
ceramide galactosyltransferase (CGT) or cerebroside
sulfotransferase (CST). These studies demonstrated
that galactolipids are important for the formation of
paranodal axo-glial junctions1)–4) and the mainte-
nance of myelin structure.5),6) In addition, several
reports suggested that sulfatide may act as a negative
regulator of oligodendrocyte terminal diﬀerentia-
tion,7),8) as terminal diﬀerentiation and morpholog-
ical maturation of oligodendrocytes were enhanced in
cultures of CGT-7) and CST-deﬁcient8) mice. Fur-
thermore, elevated numbers of diﬀerentiated oligo-
dendrocytes were found in the spinal cord and brain
of CGT-9) and CST-deﬁcient mice.8),10) Thus, sul-
fated glycolipids may be important for controlling
oligodendrocyte-lineage cell numbers in addition to
the timing of diﬀerentiation. During development,
migration, proliferation and apoptosis of oligoden-
drocyte precursor cells (OPCs) inﬂuence the total
number of oligodendrocytes. An increase in prolifer-
ation and decrease in apoptosis of oligodendrocyte-
lineage cells was observed in 15-day-old CST-
deﬁcient spinal cords,10) suggesting that changes in
these processes may, in part, be responsible for the
increase in oligodendrocytes in the adult spinal cord.
However, how the migration of OPCs is aﬀected by
conditions of sulfated glycolipid-deﬁciency is not
known, nor is it understood if these potential changes
inﬂuence the number of oligodendrocytes.
During optic nerve development, bipolar OPCs
originate from the ﬂoor of the third ventricle and
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around postnatal day 0 (P0). Some of these migrat-
ing cells reach the region of the lamina cribrosa
around P4, and can be widely seen throughout the
nerves by P7.11) During this time, oligodendrocytes
initiate terminal diﬀerentiation and myelination. The
ﬁnal number of oligodendrocytes is strictly regulated
by the induction of apoptosis in excess cells.12),13)
Thus, the developing optic nerve allows us to
highlight the migration of OPCs and to address the
timing of myelination under CST-null conditions.
In this study we focused on the numbers of
oligodendrocyte-lineage cells from the early migrat-
ing stage through adulthood and the timing of
myelination in CST-deﬁcient mouse optic nerves to
determine the role of sulfated glycolipids in the
regulation of oligodendrocyte migration, proliferation
and myelin formation. To identify oligodendrocyte-
lineage cells, we used two markers: NG2 chondroitin
sulfate proteoglycan14),15) for OPCs in both the
developing and adult optic nerves, and proteolipid
protein (PLP) for mature oligodendrocytes in the
adult.16)
Experimental procedures
CST-KO mice. CST-deﬁcient mice were
kindly provided by Dr. Koichi Honke (Kochi
University Medical School, Nankoku, Japan). Geno-
types were determined by PCR as previously describ-
ed.4) Mice were maintained in the animal facility of
the Tokyo University of Pharmacy and Life Sciences
under University Guidelines for Care and Use of
Animals. The experiments were performed after
securing the University Animal Use Committee
Protocol Approval.
Antibodies. The polyclonal antibody against
NG2 (used at 1:200) was purchased from Chemicon
(Temecula, CA). The rat monoclonal antibody
against bromodeoxyuridine (BrdU, used at 1:100)
was purchased from Abcam (Cambridge, UK). The
rabbit polyclonal antibody against single stranded
DNA17) (ssDNA, used at 1:200) was purchased from
DakoCytomation (Kyoto, Japan).
Immunoﬂuorescence. Immunohistochemistry
was performed as previously described4) with minor
modiﬁcations. Brieﬂy, CST-deﬁcient mice and wild-
type controls of various ages were ﬁxed by trans-
cardial perfusion with 4% paraformaldehyde (PFA)
in 0.1M phosphate buﬀer (PB), pH 7.4. Ten-µm-
thick cryosections of the optic nerves were permea-
bilized for one hour in 0.1M PB, containing 0.3%
Triton X-100 and 10% goat serum (PBTGS).
Primary antibodies were diluted to appropriate
concentrations in PBTGS. Alexa 488-conjugated
anti-rabbit IgG or Alexa 594-conjugated anti-rat
IgG (Molecular Probes, Eugene, OR) were used as
secondary antibodies. Sections were counterstained
with either diamidino-2-phenylindole (DAPI, Molec-
ular Probes) or propidium iodide (PI, Vector
Laboratories, Burlingame, CA). Images were cap-
tured with a Pascal laser scanning microscope (Carl
Zeiss, Oberkochen, Germany). Digitized images were
transferred to a laboratory computer for analysis
using Adobe Photoshop 6.0 (Adobe Systems, San
Jose, CA). Nerve areas were measured by AxioVision
Rel.4.6 (Carl Zeiss).
To identify proliferating cells, mice were treated
with an intraperitoneal injection of BrdU (Roche
Diagnostics, 100µg/g body weight) 24 hours before
sacriﬁce. After ﬁxation, sections were stained with
DAPI then post-ﬁxed with 4% PFA. The sections
were denatured in 2N HCl, neutralized with 0.1M
sodium borate buﬀer (pH 8.5) and extensively
washed in phosphate buﬀered saline (PBS). They
were incubated with appropriate primary and
secondary antibodies for detecting BrdU. Images
were captured by ﬂuorescence microscopy with an
AxioCam HRc CCD camera (Carl Zeiss).
For developmental studies using 1- and 2-day-
old mice, each optic nerve with the attached eyeball
was mounted in OCT compound after transcardial
ﬁxation. The blocks were cut transversely from the
eyeball. Once the tip of the optic nerve appeared, 10-
µm serial optic nerve sections were collected sequen-
tially on a total of 25 glass slides. Each slide
contained 6, 10-µm-thick sections that were a total
of 250-µm apart from each other. In total, 1.5mm
(250µm # 6) of optic nerve from each retina was
serially sectioned. Slides containing sections from 6
diﬀerent positions were prepared from two wild-type
and two CST-deﬁcient mice. This method was used
to determine the leading edge of cell migration along
the nerve. Data were collected from 6 sections at each
position and mean values were calculated.
In situ hybridization. Riboprobes were
generated from plasmids containing the following
mouse cDNAs: PLP cDNA,18) glutamate/aspartate
transporter (GLAST) cDNA,19) and macrophage
colony-stimulating factor receptor (c-fms) cDNA.20)
Digoxigenin (DIG)-labeled antisense and sense cRNA
probes were generated using a DIG RNA labeling kit
(Roche Applied Science).
In situ hybridization was performed using
methods described elsewhere20) with minor modiﬁca-
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three to four hours at 65°C in hybridization buﬀer
containing 50% formamide, 5X SSC, 200µg/mL
yeast tRNA, 100µg/mL heparin, 1X Denhardt’s
solution, 0.1% Tween-20, 0.1% CHAPS, and 5mM
EDTA. Hybridization was performed overnight with
100ng/mL riboprobe at 65°C. After pre-incubation
in the blocking buﬀer (20% heat-inactivated sheep
serum, 0.1% Triton X-100, 2mg/mL bovine serum
albumin in PBS), the sections were incubated over-
night with alkaline phosphatase-conjugated anti-DIG
antibody (Roche Diagnostics) at 4°C. Finally, the
sections were treated with freshly prepared colorizing
substrate, nitro blue tetrazolium (NBT) and 5-
bromo-4-chloro-3-indolyl-phosphate (BCIP; Roche
Diagnostics), in the presence of 5mM levamisole.
Sense probes were used as negative controls. Sections
were counterstained with nuclear fast red solution
(Sigma).
Electron microscopic analysis. Electron
microscopy was performed as described previously21)
with minor modiﬁcations. CST-deﬁcient mice and
wild-type controls at 10 days of age were ﬁxed by
transcardial perfusion followed by overnight ﬁxation
with 2% PFA and 2.5% glutaraldehyde in 0.1M
cacodylate buﬀer. Optic nerves were post-ﬁxed in 1%
osmium tetroxide in 0.1M cacodylate buﬀer for two
hours, dehydrated in ethanol, and embedded in Epon
812 (TAAB Laboratories, Berks, UK). Transverse
ultrathin sections were cut with an ultramicrotome
(EM UCG, Leica) and stained with uranyl acetate
and lead citrate. The sections were examined by
electron microscopy (JEM-1011, JEOL, Japan).
Statistical analysis. Statistical analysis was
performed using Microsoft Excel 2003 (Microsoft
Corporation). Data were expressed as the mean ’
standard error of the mean (S.E.M.). A Student’s
t-test was performed for comparisons between CST-
deﬁcient and wild-type mice. A p value of less than
0.05 was regarded as statistically signiﬁcant.
Results
The number of oligodendrocyte lineage cells
was increased in adult CST-deﬁcient optic
nerves. To determine whether the loss of sulfated
glycolipids inﬂuenced the number of oligodendrocyte
lineage cells in adult optic nerves, we measured the
numbers of mature oligodendrocytes and OPCs by
means of PLP mRNA in situ hybridization and NG2
immunohistochemistry, respectively. In 4-week-old
animals, in which myelination was still in progress,
PLP mRNA was abundantly expressed in oligoden-
drocytes from CST-deﬁcient as well as wild-type
animals (Fig. 1A and B). In contrast, expression of
PLP mRNA in 22-week-old mice was reduced in both
animals (Fig. 1C and D). Down-regulation of PLP
Fig. 1. PLP-positive cells in adult optic nerves of wild-type and CST-deﬁcient mice. (A–D) The mRNA expression pattern of the
oligodendrocyte marker PLP in 4- (A, B) and 22-week-old (C, D) wild-type (WT; D/D) and CST-deﬁcient (CSTKO; !/!) mice were
examined by in situ hybridization. Scale bar indicates 100µm. (E) Comparative cell densities of PLP mRNA-positive cells in the optic
nerves are shown. Each value represents the mean ’ SEM of the data obtained from four animals. *, P < 0.05; ***, P < 0.001 vs.
control.
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ment,22),23) and this was unchanged in the CST-
deﬁcient condition. However, more PLP mRNA-
positive mature oligodendrocytes were found in CST-
deﬁcient optic nerves than in wild-type controls at
both ages (Fig. 1E). In 4-week-old animals, OPCs
were identiﬁed with an anti-NG2 antibody (Fig. 2A
and B). The number of NG2-positive cells per area
was also higher in CST-deﬁcient mice than in wild-
type mice, although only a few NG2-positive cells
were found in the adult (Fig. 2C). The percentage of
the total number of cells comprised of NG2-positive
cells was relatively lower in CST-deﬁcient mice
(Fig. 2D), and likely due to the increase in PLP
mRNA-positive mature oligodendrocytes shown in
Fig. 1. Thus, CST-deﬁciency causes an increase in
oligodendrocyte lineage cells—primarily mature oli-
godendrocytes—in the optic nerve, which is consis-
tent with data previously reported in the adult spinal
cord.10)
To determine if other cell types exhibited
increased numbers, we counted the numbers of
astrocytes and microglia after in situ hybridization
with two RNA probes: GLAST was used for
astrocyte identiﬁcation and c-fms for microglia.20)
No signiﬁcant changes were observed in GLAST-
positive (Fig. 3A) or c-fms-positive (Fig. 3B) cell
numbers between wild-type and CST-deﬁcient mice
at both ages examined, indicating that although low
amount of sulfatide was detected in astrocytes,24)
its loss did not aﬀect the cell numbers. Thus, the
increase in cell numbers was restricted to oligoden-
drocyte lineage cells.
The increase in oligodendrocyte precursor
cells occurs prior to the onset of myelination in
the optic nerve. During normal development excess
oligodendrocytes are eliminated by programmed cell
death.12) However, our results from adult mice
suggest that the regulation of cell numbers was
aﬀected in CST-deﬁcient optic nerves. In order to
examine the changes in OPC numbers during
development, the optic nerves of 5-day-old CST-
deﬁcient and wild-type mice were stained with an
anti-NG2 antibody. Total cell numbers were deter-
mined by nuclear staining using PI. As shown in
Fig. 4, NG2-positive cells in 5-day-old animals
appeared to have ﬁne cell processes and were aligned
between the nerve ﬁbers (Fig. 4A–F), indicating that
they were post-migratory OPCs. Total numbers of
PI-positive cells (Fig. 4G), the number of NG2-
positive cells (Fig. 4H), and the ratio of NG2-positive
cells to the total number of cells (Fig. 4I) were
signiﬁcantly increased in mutant compared to wild-
type optic nerves. In 5-day-old optic nerves, marker
proteins for mature myelin, including PLP, myelin-
Fig. 2. NG2-positive cells in the optic nerve of 4-week-old wild-
type and CST-deﬁcient mice. (A, B) The expression pattern of
the oligodendrocyte precursor cell marker, NG2, in wild-type
(WT; D/D) and CST-deﬁcient (CSTKO; !/!) mouse optic
nerves were examined using an antibody speciﬁc to NG2. Scale
bar indicates 50µm. (C) Comparative cell densities of NG2-
positive cells are shown. (D) The total cell number and number
of NG2-positive cells were counted in each nerve area and the
percentage of NG2-positive cells was calculated. Each value
represents the mean ’ SEM of the data obtained from four
animals. *, P < 0.05; ***, P < 0.001 vs. control.
Fig. 3. GLAST- and c-fms-positive cells in optic nerves of wild-
type and CST-deﬁcient adult mice. The cell densities of
astrocytes and microglia were examined by in situ hybridization
using the cell-speciﬁc markers, GLAST (A) and c-fms (B),
respectively. Each value represents the mean ’ SEM of the data
obtained from four animals.
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were not detected by immunohistological analysis,
demonstrating that neither wild-type nor CST-
deﬁcient oligodendrocytes formed myelin at this age
(data not shown). Thus, the number of OPCs was
increased in CST-deﬁcient mice prior to myelination.
To determine if cell death or proliferation was
in part responsible for the increase in cell numbers
at postnatal day 5, ssDNA- or BrdU-positive cell
numbers were counted and compared between CST-
deﬁcient and wild-type optic nerves. Apoptotic cells
positive for ssDNA17) were rarely found in either
group of animals (Fig. 4J). No signiﬁcant diﬀerence
was observed in the numbers of BrdU-positive
cells (Fig. 4K), suggesting that the increase in cell
numbers occurred before BrdU incorporation at 4
days of age.
CST-deﬁcient optic nerves show an increase
in proliferating NG2-positive cells during early
stages of development. During optic nerve
development, bipolar-shaped OPCs migrate from
the brain toward the retina. They express NG2 and
platelet derived growth factor receptor , on their
surface. These markers are also present in early and
late OPCs. Sulfated glycolipids produced by CST8)
appear in late OPC stage.16) To detect migrating
and proliferating cells, we administrated BrdU to
0- and 2-day-old wild-type and CST-deﬁcient mice.
After 24 hours, serial transverse sections were
obtained by cutting the optic nerves from the retinal
to the chiasmal sides (Fig. 5A). Size of each cross
section was measured and no signiﬁcant diﬀerence
was observed between two groups in all positions.
The average number of cells per nerve area was
calculated at six diﬀerent distances away from the
retina as described in the materials and methods.
This method allowed for a direct comparison of NG2-
positive cells at each position between wild-type and
CST-deﬁcient animals.
In wild-type mice (white columns in the graphs
in Fig. 5) NG2-positive cells were abundant at
the chiasmal side (red cells in F), and these cells
gradually decreased toward the retinal side (B
compared to D). No NG2-positive OPCs were present
at the migration endpoint (position 1) at one day of
age (day 1; Fig. 5H), while two days later some
OPCs had reached the endpoint (Fig. 5K). Also, the
number of NG2-positive cells (Fig. 5H and K) and
the ratio of NG2-positive cells to total cells (Fig. 5I
and L) increased at all positions between day 1 and
day 3. The ratios of proliferating NG2-positive cells
to the total number of NG2-positive cells were
relatively lower in the regions at the forefront of
migration (position 2 at day 1 and position 1 at
day 3) in both ages (Fig. 5J and M). Thus, OPCs
actively migrate and proliferate during these two
days in normal development.
In 1-day-old CST-deﬁcient mice (blue columns),
the number of NG2-positive cells and the ratio of
NG2-positive cells to total cells at position 2 were
similar to wild-type (Fig. 5H and I), suggesting that
the number of OPCs at the migration forefront
was not diﬀerent in these two types of animals. In
contrast, the ratio of NG2-positive cells to total cells
(Fig. 5I) and the ratio of proliferating NG2-positive
cells to total NG2-positive cells (Fig. 5J) in the
mutant mice were signiﬁcantly higher than those in
wild-type at all other positions at day 1. In 3-day-old
mice, the number of NG2-positive cells and ratios
were higher in the mutants at all positions (Fig. 5K
and L). These results suggest that during early
development the increase in OPCs in mutant optic
nerves is due to an increase in OPC proliferation
rather than diﬀerences in migration.
Inﬂuence of sulfatide loss on the onset of
myelination. Primary cultures of CST-deﬁcient
oligodendrocytes showed early expression of MBP.8)
Additionally, an increase in the number of terminally
diﬀerentiated oligodendrocytes, as determined by
PLP mRNA expression, was found in various brain
regions in 7-day-old CST-deﬁcient mice.8) These
studies using molecular markers for myelin suggest
an earlier onset of myelination in CST-deﬁcient mice.
However, myelin formation itself was not directly
examined. Therefore, to determine the inﬂuence of
CST-deﬁciency on the timing of myelination in vivo,
the number of myelinated axons was determined by
electron microscopic analysis (Fig. 6A and B). In 10-
day-old CST-deﬁcient mice, a decreased percentage
of axons covered with compact myelin was found
(Fig. 6C), suggesting that myelination is delayed in
mutant optic nerves.
Discussion
In the present study, we demonstrated that the
number of mature oligodendrocytes was signiﬁcantly
increased in the optic nerves of adult CST-deﬁcient
animals. This increase in oligodendrocyte-lineage
cells occurred early in development, indicated by
the higher numbers of NG2-positive OPCs present
in 5-day-old CST-deﬁcient optic nerves. Given that
this diﬀerence was not observed at the forefront of
migration and the percentages of proliferating NG2-
positive cells were higher in 1- and 3-day-old mutant
Oligodendrocytes in sulfatide-null optic nerve No. 7] 419mice, it can be concluded that CST-deﬁciency aﬀects
proliferation but not migration of OPCs. In spite of
the increase in OPCs, the appearance of myelin
sheaths was relatively delayed in development. Thus,
during early development, sulfated glycolipids regu-
late the number of oligodendrocyte lineage cells by
controlling proliferation after migration and the
onset of myelination in the optic nerve.
A previous report by Hirahara et al.8) showed
that the number of PLP mRNA-positive mature
oligodendrocytes was increased in the brain of 7-day-
old CST-deﬁcient mice where myelination had just
Fig. 4. Number of OPCs and the proportion of dying or proliferating cells in 5-day-old optic nerves of wild-type and CST-deﬁcient mice.
(A–F) Double labeling of NG2 (green)/PI (red) was performed on optic nerves from 5-day-old wild-type (D/D;A –C) and CST-
deﬁcient (!/!;D –F) mice. Scale bar represent 25µm. (G–I) Total cell numbers (G) or the number of NG2-positive cells (H) per area,
and percentages of NG2-positive cells (I) in both wild-type (WT) and CST-deﬁcient (CSTKO) optic nerves are shown. (J, K) One day
after BrdU injection, the densities of dying cells (J) and proliferating cells (K) were examined using speciﬁc antibodies against ssDNA
or BrdU, respectively. Each value represents the mean ’ SEM of the data obtained from three individual animals of each genotype.
*, P < 0.05; ***, P < 0.001 vs. control.
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mice demonstrated that numerous CC1-positive
oligodendrocytes were maintained in the spinal cord
through at least 7 months of age.10) Our present
study adds to this evidence by showing that increases
in oligodendrocytes were also found in 4-week-old
(at which point myelination has almost terminated)
and 22-week-old optic nerves. Taken together,
Fig. 5. Regional diﬀerences in OPC numbers during early development of optic nerves in wild-type and CST-deﬁcient mice. Transverse
serial cryosections (10µm) were prepared by cutting 1-day-old (H–J) and 3-day-old (B–G; K–M) optic nerves of wild-type and CST-
deﬁcient mice from the retinal to the chiasmal side. (A) A schematic representation of the optic nerve regions (positions 1 to 6) is
illustrated. Optic nerves of wild-type (D/D) and CST-deﬁcient (!/!) mice were divided into six regions (250µm each, for a total of
1.5mm; see the materials and methods for details). (B–G) The 10-µm-thick sections from each region were triple stained with NG2
(red), BrdU (green) and DAPI (blue). Representative pictures in B/C, D/E, and F/G were obtained from positions 1, 3 and 6,
respectively. (H–M) The average number of NG2-positive cells per nerve area (H, K), percentages of NG2-positive cells (I, L) and
percentages of BrdU-positive cells in NG2-positive cell populations (J, M) from three sections at each optic nerve position are
represented as mean ’ SEM. Each value represents the mean of the data obtained from two individual animals (H–J; 1-day-old mice)
and three individual animals (K–M; 3-day-old mice) of each genotype. *, P < 0.05; ***, P < 0.001 vs. control.
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dendrocytes can be observed during myelinating
stages and greater numbers of oligodendrocytes are
sustained into adulthood in various CNS regions.
Similar increases in diﬀerentiated oligodendrocytes
were also reported in CGT-deﬁcient mice,7),9) sug-
gesting that the loss of sulfatide is predominantly
responsible for the changes in cell numbers observed
in the CNS.
In normal animals, the number of oligodendro-
cytes is strictly regulated by axons during develop-
ment. The number of myelinating cells that survive
appears to be precisely matched to the number and
length of axons requiring myelination; this is
achieved by competition for limiting amounts of
survival signals (for review25)). Our previous study4)
showed that nodal numbers (as indicated by sodium
channel clusters) were not signiﬁcantly changed in 4-
week-old CST-deﬁcient optic nerves, indicating that
the length of each myelin segment was not aﬀected.
Additionally, the study by Shroﬀ et al.10) revealed
that oligodendrocytes in 2-day-old CST-deﬁcient
spinal cords appeared to have fewer processes,
indicating that axons may require a greater number
of oligodendrocytes to compensate for the fewer
number of oligodendrocytic processes. Although it is
still unknown if oligodendrocytes with fewer proc-
esses are present in the adult, under conditions of
CST-deﬁciency each oligodendrocyte may form less
myelin rather than surviving without having formed
any myelin at all.
The present results shown in Fig. 5 indicate
that proliferation of NG2-positive cells primarily
occurred after migration; an increase in proliferating
cells may explain the diﬀerence in NG2-positive cell
numbers between wild-type and CST-deﬁcient neo-
nates. Such dysregulation of OPC numbers in early
development may be responsible, at least in part,
for the increase in oligodendrocyte-lineage cells in
adults. Thus, the loss of glycolipids results in
changes in OPC proliferation but not migration
during early development. Competitive PCR analy-
sis detected a low level of CST mRNA at embryonic
day 11.5 in brain which was followed by an up-
regulation as development progressed, with the
highest levels appearing in the adult brain.8) Sulfa-
tide expression is initiated in pre-myelinating oligo-
dendrocytes when CST expression surges.16) Loss
of the CST enzyme resulted in the absence of
proligodendroblast antigen (POA),8) which is ex-
pressed in late OPCs prior to the appearance of
sulfatide.26) Thus, both POA and sulfatide are likely
candidates for being responsible for the inhibition of
post-migratory OPC proliferation in normal devel-
oping optic nerves.
Several reports have demonstrated that sulfatide
inhibits terminal diﬀerentiation both in vitro7),8) and
in vivo.8) However, our electron microscopic analysis
did not show an earlier onset of myelination in 10-
day-old CST-deﬁcient mouse optic nerves. In vivo,
the onset of CNS myelination is inﬂuenced by
interactions with axons or other surrounding cells,
including astrocytes.27)–33) It is possible that these
interactions may compensate for the loss of sulfatide
in the mutant optic nerve.
The molecular mechanisms underlying these
changes caused by loss of sulfated glycolipids are
currently unknown. Previous studies have demon-
strated the variety of sulfatide function. Negatively
charged sulfatide is known to bind to positively
charged proteins, including extracellular matrix
proteins like laminin,34) tenascin-R,35) and tenascin-
C.36) Sulfatide may also play a role in regulating the
associations between proteins and lipid rafts, as
suggested by the change in neurofascin 155 in
cholesterol-enriched fractions in the CGT-deﬁcient
CNS.37) It has been reported that sulfatide mediates
intracellular signaling pathways, including increased
cytoplasmic calcium concentration, by acting as a
receptor of extracellular signals.38) Without sulfated
glycolipids, OPCs may fail to receive exogenous
signals resulting in the observed changes in OPC
proliferation and onset of myelination.
Fig. 6. Myelinated axons in 10-day-old CST-deﬁcient optic
nerves. (A, B) Optic nerves prepared from 10-day-old wild-type
(A) and CST-deﬁcient (B) mice were examined by electron
microscopy. (C) The percentages of myelinated axons are shown.
Each value represents the mean ’ SEM of the data obtained
from two animals of each genotype. *, P < 0.001 vs. control.
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